Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Kevin A. Ford, Gregory Ryslik, Jasleen Sodhi, Jason Halladay, Dolo Diaz, Donna Dambach & Melisa Masuda. (2015) Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications. Drug Metabolism Reviews 47:3, pages 291-319.
Read now
Read now
Yohei Kosugi & Junzo Takahashi. (2015) Species differences and substrate specificity of CYP3A heteroactivation by efavirenz. Xenobiotica 45:4, pages 345-352.
Read now
Read now
Takushi Kanazu, Noboru Okamura, Yoshitaka Yamaguchi, Takahiko Baba & Masahiro Koike. (2005) Assessment of the hepatic and intestinal first-pass metabolism of midazolam in a CYP3A drug–drug interaction model rats. Xenobiotica 35:4, pages 305-317.
Read now
Read now
T. Kanazu, Y. Yamaguchi, N. Okamura, T. Baba & M. Koike. (2004) Model for the drug–drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats. Xenobiotica 34:5, pages 403-413.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
Articles from other publishers (2)
Tyler B. Hughes, Na Le Dang, Ayush Kumar, Noah R. Flynn & S. Joshua Swamidass. (2020) Metabolic Forest: Predicting the Diverse Structures of Drug Metabolites. Journal of Chemical Information and Modeling 60:10, pages 4702-4716.
Crossref
Crossref
Takushi Kanazu, Norihito Sato, Kyoko Kadono, Akira Touchi, Yuri Takeda, Yoshitaka Yamaguchi & Takahiko Baba. (2012) Investigation of drug-drug interaction via mechanism-based inhibition of cytochrome P450 3A by macrolides in dexamethasone-treated female rats. Biopharmaceutics & Drug Disposition 33:4, pages 195-206.
Crossref
Crossref